AstraZeneca PLC (AZNCF)
130.24
+1.04
(+0.80%)
USD |
OTCM |
Nov 14, 16:00
AstraZeneca Debt to Equity Ratio: 0.8173 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.8173 |
| March 31, 2024 | 0.8895 |
| December 31, 2023 | 0.7024 |
| September 30, 2023 | 0.7419 |
| June 30, 2023 | 0.7725 |
| March 31, 2023 | 0.8534 |
| December 31, 2022 | 0.7635 |
| September 30, 2022 | 0.8089 |
| June 30, 2022 | 0.7966 |
| March 31, 2022 | 0.8297 |
| December 31, 2021 | 0.7587 |
| September 30, 2021 | 0.7787 |
| June 30, 2021 | 1.710 |
| March 31, 2021 | 1.348 |
| December 31, 2020 | 1.261 |
| September 30, 2020 | 1.777 |
| June 30, 2020 | 1.562 |
| March 31, 2020 | 1.663 |
| December 31, 2019 | 1.337 |
| September 30, 2019 | 1.434 |
| June 30, 2019 | 1.401 |
| March 31, 2019 | 1.990 |
| December 31, 2018 | 1.533 |
| September 30, 2018 | 1.752 |
| June 30, 2018 | 1.555 |
| Date | Value |
|---|---|
| March 31, 2018 | 1.537 |
| December 31, 2017 | 1.19 |
| September 30, 2017 | 1.301 |
| June 30, 2017 | 1.445 |
| March 31, 2017 | 1.334 |
| December 31, 2016 | 1.125 |
| September 30, 2016 | 1.353 |
| June 30, 2016 | 1.292 |
| March 31, 2016 | 1.100 |
| December 31, 2015 | 0.809 |
| September 30, 2015 | 0.631 |
| June 30, 2015 | 0.6022 |
| March 31, 2015 | 0.6175 |
| December 31, 2014 | 0.547 |
| September 30, 2014 | 0.4855 |
| June 30, 2014 | 0.4522 |
| March 31, 2014 | 0.477 |
| December 31, 2013 | 0.4424 |
| September 30, 2013 | 0.4378 |
| June 30, 2013 | 0.4433 |
| March 31, 2013 | 0.458 |
| December 31, 2012 | 0.4309 |
| September 30, 2012 | 0.4952 |
| June 30, 2012 | 0.423 |
| March 31, 2012 | 0.4361 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.7024
Minimum
Dec 2023
1.777
Maximum
Sep 2020
1.062
Average
0.8297
Median
Mar 2022
Debt to Equity Ratio Benchmarks
| Adaptimmune Therapeutics PLC | 0.2592 |
| Biodexa Pharmaceuticals PLC | -- |
| Verona Pharma PLC | 0.9197 |
| NuCana PLC | -- |
| Autolus Therapeutics PLC | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 104.34B |
| Total Liabilities (Quarterly) | 64.74B |
| Shareholders Equity (Quarterly) | 39.51B |
| Current Ratio | 0.8889 |
| Net Debt Paydown Yield | -0.14% |